Vortioxetine for Major Depressive Disorder in Children: 12-Week Randomized, Placebo-Controlled Study
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD); https://clinicaltrials.gov/study/NCT02709655.
Authors
- Michael Huß (ORCID: https://orcid.org/0000-0002-1113-8537)
- Melissa P. DelBello (ORCID: https://orcid.org/0000-0003-1837-4126)
- Oscar Necking
- Robert L. Findling (ORCID: https://orcid.org/0000-0002-7654-5782)
- Monika Rosén (ORCID: https://orcid.org/0000-0002-2815-8294)
- Maria Petersen (ORCID: https://orcid.org/0000-0002-2302-8212)
- Simon Nitschky Schmidt (ORCID: https://orcid.org/0000-0002-8754-1875)
Institutions
- Lundbeck (Denmark) (DK)
- Virginia Commonwealth University (US)
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- JAACAP Open
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1016/j.jaacop.2024.11.002
- Citations
- 2
- Primary Topic
- Child and Adolescent Psychosocial and Emotional Development
- Type
- article
- Field-Weighted Citation Impact
- 1.28
Funders
- Eli Lilly and Company
- H. Lundbeck A/S